Cutler Group LP A Tyr Pharma Inc Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$2.63 - $5.61 $223 - $476	-85 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$4.75 - $7.54 $13,100 - $20,795	-2,758 Reduced 97.01%	85 $0
Q4 2021 Jan 18, 2022	SELL	$7.29 - $9.5 $92,444 - $120,469	-12,681 Reduced 81.69%	2,843 $21,000
Q3 2021 Oct 26, 2021	BUY	$4.22 - $12.48 $65,511 - $193,739	15,524 New	15,524 $140,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.